| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
| TNFRSF11B |
O00300
|
TNF receptor superfamily member 11b
|
|
0.16 |
0.422 |
0.808 |
| TNFSF11 |
O14788
|
TNF superfamily member 11
|
Signaling
|
4.9E-03 |
0.453 |
0.846 |
| JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
| ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
| PRL |
P01236
|
prolactin
|
Signaling
|
2.9E-07 |
0.406 |
0.885 |
| APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
| MPO |
P05164
|
myeloperoxidase
|
Enzyme
|
7.1E-15 |
0.377 |
0.923 |
| FABP1 |
P07148
|
fatty acid binding protein 1
|
|
9.8E-07 |
0.588 |
0.692 |
| LGALS1 |
P09382
|
galectin 1
|
Signaling
|
4.5E-03 |
0.435 |
0.846 |
| BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
| CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
| PTPN1 |
P18031
|
protein tyrosine phosphatase non-receptor type 1
|
|
0.81 |
0.523 |
0.731 |
| IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
| CBL |
P22681
|
Cbl proto-oncogene
|
Enzyme
|
6.1E-04 |
0.527 |
0.769 |
| GPT |
P24298
|
glutamic--pyruvic transaminase
|
Enzyme
|
3.6E-19 |
0.403 |
0.923 |
| CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| MTTP |
P55157
|
microsomal triglyceride transfer protein
|
Transporter
|
1.0E-05 |
0.505 |
0.846 |
| ACTB |
P60709
|
actin beta
|
Cellular structure
|
0.99 |
0.325 |
0.923 |
| KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |
| MAP3K1 |
Q13233
|
mitogen-activated protein kinase kinase kinase 1
|
Kinase
|
1.00 |
0.538 |
0.731 |
| IL18R1 |
Q13478
|
interleukin 18 receptor 1
|
Receptor
|
8.6E-06 |
0.473 |
0.808 |
| EBI3 |
Q14213
|
Epstein-Barr virus induced 3
|
Signaling
|
0.11 |
0.474 |
0.808 |